Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bortin, 1992, Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988–1990 survey, Ann Intern Med, 116, 505, 10.7326/0003-4819-116-6-505
Broady, 2008, Graft-versus-host disease: suppression by statins, Nat Med, 14, 1155, 10.1038/nm1108-1155
Buckner, 1989, Clinical studies of allogeneic marrow transplantation in patients with acute non-lymphoblastic leukaemia. Seattle Marrow Transplant Team, Bone Marrow Transplant, 4, 82
2005
Chan, 1996, Toxicity and carcinogenicity of Δ9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice, Fundam Appl Toxicol, 30, 109, 10.1006/faat.1996.0048
Do, 2004, Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation, J Immunol, 173, 2373, 10.4049/jimmunol.173.4.2373
Galiègue, 1995, Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur J Biochem, 232, 54, 10.1111/j.1432-1033.1995.tb20780.x
Hakim, 1991, Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes, J Immunol, 146, 2108, 10.4049/jimmunol.146.7.2108
Hall, 2005, Cannabinoids and cancer: causation, remediation, and palliation, Lancet Oncol, 6, 35, 10.1016/S1470-2045(05)70024-3
Hegde, 2008, Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells, Mol Pharmacol, 74, 20, 10.1124/mol.108.047035
Hegde, 2010, Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties, Eur J Immunol, 40, 3358, 10.1002/eji.201040667
Jamontt, 2010, The effects of Δ-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis, Br J Pharmacol, 160, 712, 10.1111/j.1476-5381.2010.00791.x
Jia, 2006, Δ9-Tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria, Mol Cancer Res, 4, 549, 10.1158/1541-7786.MCR-05-0193
Jiang, 2011, Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization, Blood, 117, 827, 10.1182/blood-2010-01-265082
Karsak, 2007, Attenuation of allergic contact dermatitis through the endocannabinoid system, Science, 316, 1494, 10.1126/science.1142265
Klein, 2005, Cannabinoid-based drugs as anti-inflammatory therapeutics, Nat Rev Immunol, 5, 400, 10.1038/nri1602
Klein, 2000, Δ9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptor β2 responses to Legionella pneumophila infection, J Immunol, 164, 6461, 10.4049/jimmunol.164.12.6461
Korngold, 1978, Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow, J Exp Med, 148, 1687, 10.1084/jem.148.6.1687
Lombard, 2005, Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Δ9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells, Leuk Res, 29, 915, 10.1016/j.leukres.2005.01.014
Mackie, 2006, Cannabinoid receptors as therapeutic targets, Annu Rev Pharmacol Toxicol, 46, 101, 10.1146/annurev.pharmtox.46.120604.141254
Martin, 1988, Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants, Bone Marrow Transplant, 3, 445
McKallip, 2002, Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease, Blood, 100, 627, 10.1182/blood-2002-01-0098
McKallip, 2002, Δ9-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo, J Pharmacol Exp Ther, 302, 451, 10.1124/jpet.102.033506
McKallip, 2005, Δ-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response, J Immunol, 174, 3281, 10.4049/jimmunol.174.6.3281
Michalski, 2007, Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis, Gastroenterology, 132, 1968, 10.1053/j.gastro.2007.02.035
Mori, 1998, Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression, Blood, 92, 101, 10.1182/blood.V92.1.101.413k14_101_107
Nagarkatti, 2010, Do cannabinoids have a therapeutic role in transplantation?, Trends Pharmacol Sci, 31, 345, 10.1016/j.tips.2010.05.006
Nagarkatti, 2009, Cannabinoids as novel anti-inflammatory drugs, Future Med Chem, 1, 1333, 10.4155/fmc.09.93
Pandey, 2009, Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis, Vitam Horm, 81, 487, 10.1016/S0083-6729(09)81019-4
Pertwee, 2009, Emerging strategies for exploiting cannabinoid receptor agonists as medicines, Br J Pharmacol, 156, 397, 10.1111/j.1476-5381.2008.00048.x
Pertwee, 2002, Cannabinoid receptors and their ligands, Prostaglandins Leukot Essent Fatty Acids, 66, 101, 10.1054/plef.2001.0341
Poynton, 1988, T cell depletion in bone marrow transplantation, Bone Marrow Transplant, 3, 265
Ramer, 2010, Cannabidiol inhibits cancer cell invasion via up-regulation of tissue inhibitor of matrix metalloproteinases-1, Biochem Pharmacol, 79, 955, 10.1016/j.bcp.2009.11.007
Rezvani, 2006, High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT, Blood, 108, 1291, 10.1182/blood-2006-02-003996
Rieder, 2010, Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression, Immunobiology, 215, 598, 10.1016/j.imbio.2009.04.001
Storb, 1986, Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia, N Engl J Med, 314, 729, 10.1056/NEJM198603203141201
Via, 1987, Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease, J Immunol, 139, 1840, 10.4049/jimmunol.139.6.1840
Via, 1988, T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease, Immunol Today, 9, 207, 10.1016/0167-5699(88)91215-7
Welniak, 2007, Immunobiology of allogeneic hematopoietic stem cell transplantation, Annu Rev Immunol, 25, 139, 10.1146/annurev.immunol.25.022106.141606